APA

Büller H. R., Davidson B. L., Decousus H., Gallus A., Gent M., Piovella F., Prins M. H., Raskob G., van den Berg-Segers A. E. M., Cariou R., Leeuwenkamp O. & Lensing A. W. A. (20031105). Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. : The New England journal of medicine.

Chicago

Büller H R, Davidson B L, Decousus H, Gallus A, Gent M, Piovella F, Prins M H, Raskob G, van den Berg-Segers A E M, Cariou R, Leeuwenkamp O and Lensing A W A. 20031105. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. : The New England journal of medicine.

Harvard

Büller H. R., Davidson B. L., Decousus H., Gallus A., Gent M., Piovella F., Prins M. H., Raskob G., van den Berg-Segers A. E. M., Cariou R., Leeuwenkamp O. and Lensing A. W. A. (20031105). Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. : The New England journal of medicine.

MLA

Büller H R, Davidson B L, Decousus H, Gallus A, Gent M, Piovella F, Prins M H, Raskob G, van den Berg-Segers A E M, Cariou R, Leeuwenkamp O and Lensing A W A. Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. : The New England journal of medicine. 20031105.